125 related articles for article (PubMed ID: 12242732)
1. The value of power Doppler imaging to predict the histologic components of benign prostatic hyperplasia.
Hayami S; Ushiyama T; Kurita Y; Kageyama S; Suzuki K; Fujita K
Prostate; 2002 Oct; 53(2):168-74. PubMed ID: 12242732
[TBL] [Abstract][Full Text] [Related]
2. Role of Doppler ultrasound and resistive index in benign prostatic hypertrophy.
Tsuru N; Kurita Y; Masuda H; Suzuki K; Fujita K
Int J Urol; 2002 Aug; 9(8):427-30. PubMed ID: 12225338
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the resistive index of prostatic blood flow in benign prostatic hyperplasia.
Abdelwahab O; El-Barky E; Khalil MM; Kamar A
Int Braz J Urol; 2012; 38(2):250-5; discussion 255-7. PubMed ID: 22555031
[TBL] [Abstract][Full Text] [Related]
4. The measurement of the prostatic resistive index is a reliable ultrasonographic tool to stratify symptoms of patients with benign prosthatic hyperplasia.
Yencilek E; Koyuncu H; Arslan D; Bastug Y
Med Ultrason; 2014 Sep; 16(3):208-13. PubMed ID: 25110761
[TBL] [Abstract][Full Text] [Related]
5. Doppler resistive index in benign prostatic hyperplasia: correlation with ultrasonic appearance of the prostate and infravesical obstruction.
Kojima M; Ochiai A; Naya Y; Okihara K; Ukimura O; Miki T
Eur Urol; 2000 Apr; 37(4):436-42. PubMed ID: 10765074
[TBL] [Abstract][Full Text] [Related]
6. Transition zone ratio and prostate-specific antigen density: the index of response of benign prostatic hypertrophy to an alpha blocker.
Kurita Y; Ushiyama T; Suzuki K; Fujita K; Kawabe K
Int J Urol; 1996 Sep; 3(5):361-6. PubMed ID: 8886912
[TBL] [Abstract][Full Text] [Related]
7. The importance of prostatic measuring by transrectal ultrasound in surgical management of patients with clinically benign prostatic hyperplasia.
Milonas D; Trumbeckas D; Juska P
Medicina (Kaunas); 2003; 39(9):860-6. PubMed ID: 14515048
[TBL] [Abstract][Full Text] [Related]
8. Correlations among cardiovascular risk factors, prostate blood flow, and prostate volume in patients with clinical benign prostatic hyperplasia.
Chen IH; Tsai YS; Tong YC
Urology; 2012 Feb; 79(2):409-14. PubMed ID: 22137544
[TBL] [Abstract][Full Text] [Related]
9. Role of the transition zone for elevating serum prostate-specific antigen in benign prostatic hyperplasia.
Sakamoto W; Iwata H; Kamikawa S; Tsurusaki K; Sugimoto T; Nakatani T; Sugimura K; Yamamoto K; Kishimoto T
Int J Urol; 1998 Mar; 5(2):163-6. PubMed ID: 9559843
[TBL] [Abstract][Full Text] [Related]
10. Association of free-prostate specific antigen subfractions and human glandular kallikrein 2 with volume of benign and malignant prostatic tissue.
Steuber T; Niemela P; Haese A; Pettersson K; Erbersdobler A; Felix Chun KH; Graefen M; Kattan MW; Huland H; Lilja H
Prostate; 2005 Apr; 63(1):13-8. PubMed ID: 15378521
[TBL] [Abstract][Full Text] [Related]
11. Diagnostic approach to prostate cancer using total prostate specific antigen-based parameters together.
Serdar MA; Oguz O; Olgun A; Seçkin B; Ilgan S; Hasimi A; Salih M; Peker F; Kutluay T
Ann Clin Lab Sci; 2002; 32(1):22-30. PubMed ID: 11848613
[TBL] [Abstract][Full Text] [Related]
12. Relationship between serum prostate-specific antigen and calculated epithelial volume.
Fukatsu A; Ono Y; Ito M; Yoshino Y; Hattori R; Gotoh M; Ohshima S
Urology; 2003 Feb; 61(2):370-4. PubMed ID: 12597950
[TBL] [Abstract][Full Text] [Related]
13. Determination of transition zone volume by transrectal ultrasound in patients with clinically benign prostatic hyperplasia: agreement with enucleated prostate adenoma weight.
Baltaci S; Yagci C; Aksoy H; Elan AH; Gögüs O
J Urol; 2000 Jul; 164(1):72-5. PubMed ID: 10841600
[TBL] [Abstract][Full Text] [Related]
14. Changes in serum prostate-specific antigen following prostatectomy in patients with benign prostate hyperplasia.
Furuya Y; Akakura K; Tobe T; Ichikawa T; Igarashi T; Ito H
Int J Urol; 2000 Dec; 7(12):447-51. PubMed ID: 11168683
[TBL] [Abstract][Full Text] [Related]
15. Is one single prostate biopsy helpful for choosing a medical treatment of benign prostatic hyperplasia? A quantitative computerized morphometric study.
Zlota Ar; Sattar AA; Wespes E; Noel JC; Schulman CC
Urology; 1996 Mar; 47(3):329-34. PubMed ID: 8633397
[TBL] [Abstract][Full Text] [Related]
16. Morphometric analysis of prostate zonal anatomy using magnetic resonance imaging: impact on age-related changes in patients in Japan and the USA.
Matsugasumi T; Fujihara A; Ushijima S; Kanazawa M; Yamada Y; Shiraishi T; Hongo F; Kamoi K; Okihara K; de Castro Abreu AL; Oishi M; Shin T; Palmer S; Gill IS; Ukimura O
BJU Int; 2017 Oct; 120(4):497-504. PubMed ID: 28220583
[TBL] [Abstract][Full Text] [Related]
17. [Bi-planar transrectal ultrasonographic study on the diagnosis of hyperplasia prostate gland].
Que YH; Wang XM
Zhonghua Nan Ke Xue; 2005 Mar; 11(3):191-4. PubMed ID: 15804110
[TBL] [Abstract][Full Text] [Related]
18. Serum BPSA outperforms both total PSA and free PSA as a predictor of prostatic enlargement in men without prostate cancer.
Canto EI; Singh H; Shariat SF; Lamb DJ; Mikolajczyk SD; Linton HJ; Rittenhouse HG; Kadmon D; Miles BJ; Slawin KM
Urology; 2004 May; 63(5):905-10; discussion 910-1. PubMed ID: 15134977
[TBL] [Abstract][Full Text] [Related]
19. Transrectal ultrasound parameters: presumed circle area ratio and transitional zone area in the evaluation of patients with lower urinary tract symptoms.
Desai MM
J Endourol; 1999 May; 13(4):317-21. PubMed ID: 10405914
[TBL] [Abstract][Full Text] [Related]
20. Calculated fast-growing benign prostatic hyperplasia--a risk factor for developing clinical prostate cancer.
Hammarsten J; Högstedt B
Scand J Urol Nephrol; 2002; 36(5):330-8. PubMed ID: 12487736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
